Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

ACD Wins $3 Million Grant From National Cancer Institute to Develop Its CTCscope™ System for Detection and Molecular Analysis of Circulating Tumor Cells

October 8, 2010 By Bio-Medicine.Org

HAYWARD, Calif., Oct. 8 /PRNewswire/ — Advanced Cell
Diagnostics, Inc. (ACD) was awarded a three-year, $3 million grant
from National Cancer Institute (NCI) under its SBIR Phase II Bridge
Award. This grant will support ACD’s continuing effort to develop
its proprietary CTCscope™ system capable of automatic
detection and molecular characterization of circulating tumor cells
(CTCs). CTCs are the rare tumor cells detached from solid tumors
and circulating in cancer patients’ blood.

“We are very grateful for the continued support from NCI. The
previous Phase I and Phase II grants have helped ACD to develop the
underlying RNAscope™ technology, which has since been
translated successfully into Research Use Only products for in
situ
detection of RNA biomarkers in FFPE samples,” commented by
Dr. Yuling Luo, President & CEO of ACD.  “Given how few of
these grants are given, the award is a further validation of the
strength of our technology to uniquely fulfill a critical unmet
clinical need in cancer management.” ACD has since been featured as
one of the NCI SBIR Success Stories (http://sbir.cancer.gov/success/stories/acd/acd.asp).

In this latest grant, ACD will work with a multidisciplinary
team from four leading institutions to further advance
CTCscope™ into an automated system and conduct clinical
studies to demonstrate its clinical utility. Collaborators include
Dr. Paul Goodwin of Applied Precision, Drs. Hope Rugo and John Park
of University of California San Francisco, Prof. David Krag of
University of Vermont, and Prof. Charles Coombes of Imperial
College London.

About CTCscope™:

ACD’s CTCscope™ system is based on its proprietary in
situ
RNA detection platform RNAscope™, which enables
highly sensitive and specific detection of all types of CTCs
without the need for EpCAM-based enrichment. Importantly,
CTCscopeT

‘/>”/>

SOURCE

Related Articles Read More >

Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age
A Medtronic HVAD pump opened up to show the inner workings
Medtronic investigates HVAD pump welds after patient deaths
Galien Foundation 2022 nominees
18 of the world’s most innovative medical technologies

DeviceTalks Weekly.

May 13, 2022
Our Pre-Post-DeviceTalks Boston episode, also MedtronicTalks replay with Gastro CMO Austin Chiang
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech